Table 1.
Treatment | Sepsis Model | Cell/Animal | Effect | Ref. |
---|---|---|---|---|
sTREM-1 | LPS | Macrophages | ↓ mRNA of inflammatory cytokines | (69) |
S. suis intraperitoneal | Mice | ↓ serum TNF-α, IL-1β, ↓ acute lung injury, ↑ survival (when given with antibiotics) | (70) | |
TREM-1 Fc fusion protein | LPS | Monocytes | ↓ release TNF-α, IL-1β | (8) |
P. aeruginosa | Macrophages | ↓ release TNF-α, IL-1β, MCP-1 | (71) | |
S. pyogenes | Neutrophils | ↓ release IL-6, TNF-α | (72) | |
LPS intraperitoneal | Mice | ↓ serum TNF-α, IL-1β, ↓ recruitment of peritoneal macrophages and neutrophils, ↑ survival | (8) | |
CLP | Mice | ↑ survival | (8) | |
E. coli intraperitoneal | Mice | ↑ survival | (8) | |
S. pyogenes intravenous | Mice | ↓ serum IL-6, TNF-α, ↑ survival | (72) | |
P. aeruginosa intraperitoneal | Mice | ↓ serum IL-1β, TNF-α, MCP-1, ↑ survival | (71) | |
LP17 | LPS | Monocytes | ↓ release TNF-α, IL-1β | (73) |
E. coli | Neonatal leukocytes | ↓ release TNF-α, IL-6, IL-8 | (74) | |
LPS intraperitoneal | Mice | ↑ survival | (35) | |
CLP | Mice | ↓ serum TNF-α, IL-1β, ↑ survival | (73) | |
S. pyogenes intravenous | Mice | ↑ survival | (72) | |
LPS intraperitoneal | Rats | ↑ hemodynamics, ↓ serum TNF-α, IL-1β | (35) | |
CLP | Rats | ↑ hemodynamics, ↓ TNF-α, IL-1β, IL-6, ↑ survival | (35, 75) | |
P. aeruginosa intratracheal | Rats | ↓ serum and broncoalveolar lavage TNF-α, IL-1β, IL-6, lactic acidosis, hypoxia, ↑ hemodynamics, ↑ survival | (76) | |
GF9 | LPS | Macrophages | ↓ release TNF-α, IL-1β, IL-6 | (77) |
LPS intraperitoneal | Mice | ↓ serum TNF-α, IL-1β, IL-6, ↑ survival | (77) | |
SLC-TREM-1 | LPS | Endothelium | ↓ TREM-1 expression, ↓ MCP-1, IL-8 release | (78) |
CLP | Mice | ↑ survival | (78) | |
M3 | LPS intraperitoneal | Mice | ↓ serum TNF-α, IL-6, ↑ survival | (41) |
CLP | Mice | ↓ serum AST, ALT, TNF-α, IL-6, ↓ acute lung injury, ↑ survival | (41) | |
Cecal Slurry | Neonatal Mice | ↓ serum TNF-α, IL-1β, IL-6, INFγ, ↓ cardiac and pulmonary IL-1β, IL-6, ↓ cardiac dysfunction, ↑ survival | (79) | |
N1 | LPS | Mononuclear Cells/Monocytes | ↓ mRNA TNF-α, IFNγ, IL-1β, and IL-6 | (80) |
LPS intrabronchial | Mice | ↓ serum INFγ, IL-4, ↓ lung damage | (80) | |
LR17/LR12 | LPS | Granulocyte | ↓ mRNA and protein TNF-α, IL-8, IL-10, ↓ ROS production | (23) |
LPS | Monocytes | ↓ release TNF-α | (23) | |
LPS intraperitoneal | Mice | ↓ serum TNF-α, IL-6, IL-10, ↑ survival | (23) | |
CLP | Mice | ↓ cytokines in serum, peritoneal and bronchoalveolar fluid, liver, lung, ↓ acute lung injury, ↓ bacteria in spleen, blood, ↓ TREM-1 expression, ↑ survival | (23, 57) | |
Cecal Slurry | Pigs | ↑ cardiac function, ↓ coagulopathy, ↓ failure of lungs, liver, kidney, ↑survival | (68) | |
LPS intravenous | Monkeys | ↑ hemodynamics, ↓ serum cytokines | (81) | |
Nangibotide | Sepsis | Humans | ↓ systemic IL-6, ↓ SOFA scores, minimal side effects | (82, 83) |
↓- decreased; ↑- increased.